Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
7%
Antibiotic Agent
21%
Antibiotics
11%
Bronchiolitis Obliterans
11%
Cell Culture
39%
Cell Viability
15%
Chronic Obstructive Lung Disease
9%
Controlled Release
9%
Cromoglicic Acid
8%
Cystic Fibrosis
30%
Differential Scanning Calorimetry
12%
Dipalmitoylphosphatidylcholine
28%
Dipalmitoylphosphatidylglycerol
13%
Disease
14%
Dosage Forms
11%
Drug Dose
7%
Drug Release
13%
Dry Powder Inhaler
100%
Fluticasone Propionate
8%
Formoterol
16%
Glycopeptide
12%
Ipratropium Bromide
8%
Lactose
19%
Lung Cancer
25%
Lung Disease
19%
Mannitol
16%
Microparticle
38%
Nanocarrier
16%
Nanomedicine
31%
Nanoparticle
61%
Paclitaxel
20%
Peptides and Proteins
9%
Pharmaceutics
11%
Phospholipid
28%
Polyglactin
13%
Polypeptide
8%
Powder Formulation
26%
Pulmonary Drug Delivery
27%
Pulmonary Hypertension
34%
Pulmonary Surfactant
30%
Raman Microscopy
8%
Receptor
7%
Respiratory Tract Disease
13%
Rho Kinase
11%
Salbutamol Sulfate
8%
Scanning Electron Microscopy
12%
Side Effect
9%
Tobramycin
9%
Transcription Factor Nrf2
17%
Trehalose
20%
Keyphrases
2D/3D Cell Culture
5%
Advanced Lung Disease
11%
Aerosol Delivery
11%
Aerosol Dispersion
13%
Air-interface Culture
6%
Albuterol Sulfate
5%
Bronchiolitis Obliterans Syndrome
7%
Carrier-free
5%
Cellular Studies
11%
Central Hemodynamics
5%
Confidence Interval
8%
Cystic Fibrosis
16%
Dispersion Study
11%
Dry Powder
8%
Dry Powder Aerosol
5%
Dry Powder Inhaler
16%
Dry Powder Inhaler Formulation
6%
Elite Swimmers
5%
Hazard Ratio
8%
Heart-lung Transplant
5%
High Performance
11%
Inhalable
6%
Inhalation Aerosols
11%
Inhalation Delivery
6%
Interface Culture
5%
Itraconazole
5%
Lactose Monohydrate
5%
Lung Cancer
11%
Lung Surfactant
11%
Lung Transplantation
22%
Microparticulate
7%
Multifunctional Particles
11%
Nanomedicine
11%
Nanoparticles
6%
Nanoparticulate
7%
Nasal Aerosol
5%
Nose-to-brain Delivery
5%
Paclitaxel
11%
Phosphatidylglycerol
11%
Physicochemical Characterization
12%
Precordial Catch Syndrome
5%
Pulmonary Hypertension
13%
Pulmonary Inhalation
11%
Raman Characterization
5%
Respirable
6%
Right Heart Catheterization
6%
Sodium Cromoglycate
5%
Standardized Entrainment Tubes
5%
Targeted Delivery
6%
Transplantation
7%
Medicine and Dentistry
Acute Respiratory Failure
5%
Advanced Lung Disease
11%
Allograft
5%
Antisynthetase Syndrome
5%
Arterial Embolization
5%
Artificial Respiration
5%
Blood Brain Barrier
5%
Bronchial Artery
5%
Bronchiectasis
5%
Bronchiolitis Obliterans
8%
Central Nervous System Disease
5%
Chemical Imaging
5%
Chronic Obstructive Pulmonary Disease
5%
Computed Tomography Angiography
5%
Cystic Fibrosis
41%
Disease
5%
Drug Delivery System
7%
Ex Vivo
5%
Hazard Ratio
13%
Hemoptysis
5%
Human Leukocyte Antigen
11%
Imaging Technique
5%
Immunosuppressive Treatment
6%
Itraconazole
5%
Lung Artery Pressure
6%
Lung Transplantation
58%
Macrophage
5%
Multidetector Computed Tomography
5%
Nanomedicine
5%
Nanoparticle
5%
Nissen Fundoplication
5%
Patient with Cystic Fibrosis
19%
Pediatrics
8%
Pediatrics Patient
5%
Posterior Reversible Encephalopathy Syndrome
5%
Prevalence
5%
Primary Graft Dysfunction
5%
Proportional Hazards Model
12%
Pulmonary Hypertension
13%
